Search
Search Results
-
Adenocarcinoma arising from widespread heterotopic gastric mucosa in the cervicothoracic esophagus: a case report
BackgroundIn Japan, about 6% of esophageal cancers are adenocarcinomas, although most of them arise from Barrett’s epithelium. Adenocarcinoma arising...
-
Risk stratification for synchronous/metachronous recurrence after endoscopic submucosal dissection for Barrett’s esophageal adenocarcinoma using the length of Barrett’s esophagus
BackgroundIn Japan, the standard management of Barrett’s esophageal adenocarcinoma after endoscopic submucosal dissection involves follow-up;...
-
Combined tubular adenocarcinoma, neuroendocrine carcinoma and adenocarcinoma with enteroblastic differentiation arising in Barrett esophagus
Adenocarcinoma (AC) with neuroendocrine carcinoma (NEC) or enteroblastic (ENT) differentiation rarely develops in Barrett’s esophagus (BE). A...
-
Optimal First-Line Therapy for Metastatic Adenocarcinoma of the Esophagus
Treatment strategies for esophageal adenocarcinoma patients continue to advance with the generation of more data from clinical trials that are...
-
Long-Term Postsurgical Outcomes of Neoadjuvant Chemoradiation (CROSS) Versus Chemotherapy (FLOT) for Multimodal Treatment of Adenocarcinoma of the Esophagus and the Esophagogastric Junction
BackgroundThe question of the ideal neoadjuvant therapy for locally advanced esophagogastric adenocarcinoma has not been answered to date. Multimodal...
-
Incidence of Esophageal Adenocarcinoma, Mortality, and Esophagectomy in Barrett’s Esophagus Patients Undergoing Endoscopic Eradication Therapy
IntroductionEndoscopic eradication therapy (EET) is the preferred treatment for Barrett’s esophagus (BE)-related neoplasia patients. However, the...
-
Long- vs short-segment Barrett’s esophagus-derived adenocarcinoma: clinical features and outcomes of endoscopic submucosal dissection
BackgroundThe incidence of Barrett’s esophageal adenocarcinoma (BEA) is increasing, and endoscopic submucosal dissection (ESD) has been frequently...
-
Neuroendocrine carcinomas of the esophagus: clinicopathological and immunohistochemical features of 43 cases
BackgroundNeuroendocrine carcinomas (NECs) of the esophagus are extremely rare and poorly understood. This study aimed to delineate the...
-
A case of superficial spreading type of poorly differentiated adenocarcinoma of the stomach with invasion to the esophagus
BackgroundInvasion is more likely to occur in gastric cancer affecting larger areas. Poorly differentiated adenocarcinoma tends to invade deep. The...
-
Histological evaluation of PAXgene tissue fixation in Barrett’s esophagus and esophageal adenocarcinoma diagnostics
The dysplasia grading of Barrett’s esophagus (BE), based on the histomorphological assessment of formalin-fixed, paraffin-embedded (FFPE) tissue,...
-
Ten-year follow-up of endoscopic mucosal resection versus esophagectomy for esophageal intramucosal adenocarcinoma in the setting of Barrett’s esophagus: a Canadian experience
BackgroundEndoscopic mucosal resection (EMR) is an effective treatment for esophageal intramucosal adenocarcinoma (IMC), with similar recurrence and...
-
Revisiting Proton Pump Inhibitors as Chemoprophylaxis Against the Progression of Barrett’s Esophagus
Purpose of ReviewBarrett’s esophagus (BE) is associated with chronic gastroesophageal reflux disease and is a known precursor to esophageal...
-
A novel anatomical description of the esophagus: the supracarinal mesoesophagus
BackgroundDuring thoracoscopic esophageal resection, while performing the supracarinal lymphadenectomy along the left recurrent laryngeal nerve...
-
CA19-9-producing esophageal adenocarcinoma originating from the esophageal cardia of the mid-thoracic esophagus: a case report
BackgroundAlthough there are many studies on primary esophageal adenocarcinoma arising from Barrett's esophagus or ectopic gastric mucosa, reports on...
-
Insights into the Paradox of the Weak Association Between Sleeve Gastrectomy and Barrett’s Esophagus
Sleeve gastrectomy (SG) is deemed a refluxogenic operation but with a low incidence of postoperative Barrett´s esophagus (BE). We aimed to shed some...
-
Staging Accuracy and Lymph Node Involvement in Superficial Adenocarcinoma and Squamous Cell Carcinoma of the Esophagus—a Multicenter Case Series Analysis
At an early stage, esophageal cancer can be removed surgically or endoscopically. T1a tumors are removed by endoscopic resection, whereas T1b tumors...
-
Synchronous cancers of the stomach and esophagus in a patient with autoimmune gastritis and pernicious anemia: a case report and review of the literature
Type-A gastritis/autoimmune gastritis (AIG) has gained renewed attention due to declining Helicobacter pylori infection rates and increasing...
-
Shining Light on Rarity: Mucoepidermoid Carcinoma of the Esophagus with Absence of MAML2 Gene Rearrangement
Primary mucoepidermoid carcinoma of the esophagus is a rare condition characterized by a combination of squamous and mucin-secreting glandular...
-
Population Based Time Trends in the Epidemiology and Mortality of Gastroesophageal Junction and Esophageal Adenocarcinoma
BackgroundLimited data are available on the epidemiology of gastroesophageal junction adenocarcinoma (GEJAC), particularly in comparison to...
-
Efficacy of Nissen Sleeve Gastrectomy on Mid-term Barrett’s Esophagus Regression
IntroductionSleeve gastrectomy is the most commonly performed bariatric operation globally. The main complication is GERD. In the medium term, it can...
